loadpatents
Patent applications and USPTO patent grants for Methot; Joey L..The latest application filed is for "indazolyl-spiro[2.2]pentane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof".
Patent | Date |
---|---|
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 11,230,547 - McGowan , et al. January 25, 2 | 2022-01-25 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 11,179,389 - McGowan , et al. November 23, 2 | 2021-11-23 |
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof Grant 11,174,248 - Acton , et al. November 16, 2 | 2021-11-16 |
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof Grant 11,161,854 - Candito , et al. November 2, 2 | 2021-11-02 |
Indazolyl-spiro[2.2]pentane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20210188863 - Candito; David Annunziato ;   et al. | 2021-06-24 |
Indazolyl-spiro[2.3]hexane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20210188818 - Acton; John ;   et al. | 2021-06-24 |
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20200392144 - McGowan; Meredeth A. ;   et al. | 2020-12-17 |
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20200390760 - McGowan; Meredeth A. ;   et al. | 2020-12-17 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 10,544,147 - Achab , et al. Ja | 2020-01-28 |
Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta App 20190119278 - Achab; Abdelghani Abe ;   et al. | 2019-04-25 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 10,221,178 - McGowan , et al. | 2019-03-05 |
Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta App 20180141947 - McGowan; Meredith Ann ;   et al. | 2018-05-24 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 9,938,281 - Achab , et al. April 10, 2 | 2018-04-10 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 9,730,940 - Achab , et al. August 15, 2 | 2017-08-15 |
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators Grant 9,469,615 - Boyce , et al. October 18, 2 | 2016-10-18 |
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20160207926 - Achab; Abdelghani Abe ;   et al. | 2016-07-21 |
Quinolines and aza-quinolines as CRTH.sub.2 receptor modulators Grant 9,290,453 - Boyce , et al. March 22, 2 | 2016-03-22 |
Compounds that are ERK inhibitors Grant 9,233,979 - Wilson , et al. January 12, 2 | 2016-01-12 |
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20150353552 - Achab; Abdelghani Abe ;   et al. | 2015-12-10 |
Amidopyrazole inhibitors of interleukin receptor-associated kinases Grant 9,169,260 - McElroy , et al. October 27, 2 | 2015-10-27 |
Novel Compounds That Are Erk Inhibitors App 20150266895 - Wilson; Kevin J. ;   et al. | 2015-09-24 |
Compounds that are ERK inhibitors Grant 9,023,865 - Lim , et al. May 5, 2 | 2015-05-05 |
Indole derivatives as CRTH2 receptor antagonists Grant 9,023,864 - Berthelette , et al. May 5, 2 | 2015-05-05 |
Quinazolinone-type compounds as CRTH.sub.2 antagonists Grant 8,927,559 - Aslanian , et al. January 6, 2 | 2015-01-06 |
Diaryl ether derivatives as notch sparing gamma secretase inhibitors Grant 8,871,796 - Brown , et al. October 28, 2 | 2014-10-28 |
Novel Compounds That Are Erk Inhibitors App 20140296203 - Lim; Jongwon ;   et al. | 2014-10-02 |
Amidopyrazole Inhibitors Of Interleukin Receptor-associated Kinases App 20140194404 - McElroy; William T. ;   et al. | 2014-07-10 |
Spirocyclic compounds Grant 8,686,020 - Hamblett , et al. April 1, 2 | 2014-04-01 |
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators App 20130303517 - Boyce; Christopher W. ;   et al. | 2013-11-14 |
Quinolines And Aza-quinolines As Crth2 Receptor Modulators App 20130296300 - Boyce; Christopher W. ;   et al. | 2013-11-07 |
Quinazolinone-type Compounds As Crth2 Antagonists App 20130210805 - Aslanian; Robert G. ;   et al. | 2013-08-15 |
Indole Derivatives as CRTH2 Receptor Antagonists App 20130150398 - Berthelette; Carl ;   et al. | 2013-06-13 |
Spirocyclic Compounds App 20130131041 - Berk; Scott C. ;   et al. | 2013-05-23 |
Diaryl Ether Derivatives As Notch Sparing Gamma Secretase Inhibitors App 20130053386 - Brown; William Colby ;   et al. | 2013-02-28 |
Spirocyclic compounds Grant 8,349,825 - Mampreian , et al. January 8, 2 | 2013-01-08 |
Silicon Derivatives As Histone Deacetylase Inhibitors App 20110130361 - Grimm; Jonathan ;   et al. | 2011-06-02 |
Spirocyclic Compounds App 20110098268 - Mampreian; Dawn M. ;   et al. | 2011-04-28 |
Spirocyclic compounds Grant 7,834,026 - Berk , et al. November 16, 2 | 2010-11-16 |
Spirocyclic Compounds App 20090209566 - Berk; Scott C. ;   et al. | 2009-08-20 |
Spirocyclic compounds Grant 7,544,695 - Berk , et al. June 9, 2 | 2009-06-09 |
Substituted Nicotinamide Compounds App 20090105264 - Hamblett; Christopher ;   et al. | 2009-04-23 |
Benzothiophene derivatives App 20090082308 - Hubbs; Jed Lee ;   et al. | 2009-03-26 |
Spirocyclic compounds App 20070117824 - Berk; Scott C. ;   et al. | 2007-05-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.